지혈 제품 시장 규모, 점유율, 성장 분석 : 제품별, 용도별, 최종 용도별, 지역별 - 산업 예측(2025-2032년)
Hemostasis Products Market Size, Share, and Growth Analysis, By Products (Topical Hemostasis, Infusible Hemostasis), By Application (Trauma, Surgery), By End Use, By Region - Industry Forecast 2025-2032
상품코드:1687574
리서치사:SkyQuest Technology Consulting Pvt. Ltd.
발행일:2025년 03월
페이지 정보:영문 219 Pages
라이선스 & 가격 (부가세 별도)
한글목차
지혈 제품 시장 규모는 2023년에 16억 9,000만 달러로 평가되며, 2024년 17억 8,000만 달러에서 2032년에는 27억 4,000만 달러로 성장하며, 예측 기간(2025-2032년)의 CAGR은 5.5%로 성장할 전망입니다.
세계 지혈 제품 시장은 의료기술의 발전과 인식 향상에 힘입어 지속적인 성장세를 보이고 있습니다. 고령화, 만성질환 및 수술 증가로 인해 수술 및 외상시 출혈을 억제하고 출혈성 질환을 관리하는 데 필수적인 이러한 제품에 대한 수요가 증가하고 있습니다. 또한 신흥 국가 시장의 의료 인프라 개선은 시장 확대를 더욱 촉진하고 있습니다. 지속적인 연구개발을 통해 혁신적이고 안전하며 효율적인 제품들이 등장하고 있습니다. 그럼에도 불구하고 규제 장벽과 이러한 제품과 관련된 높은 비용이 시장 성장에 걸림돌로 작용하고 있습니다. 이러한 장애물에도 불구하고 헬스케어 표준과 기술 혁신의 진화에 따라 시장은 지속적으로 발전하고 있습니다.
목차
서론
조사의 목적
조사 범위
정의
조사 방법
정보 조달
2차와 1차 데이터 방법
시장 규모 예측
시장의 전제조건과 제한
개요
세계 시장 전망
공급과 수요 동향 분석
부문별 기회 분석
시장 역학과 전망
시장 개요
시장 규모
시장 역학
촉진요인과 기회
억제요인과 과제
Porter의 산업 분석
주요 시장 인사이트
주요 성공 요인
경쟁의 정도
주요 투자 기회
시장 에코시스템
시장의 매력 지수(2024년)
PESTEL 분석
거시경제 지표
밸류체인 분석
가격 분석
지혈 제품 시장 규모 : 제품별 & CAGR(2025-2032)
시장 개요
국소 지혈
콜라겐
산화 재생 셀룰로오스
젤라틴
다당류
수액 지혈
도너 혈액으로부터의 혈소판 농축물
혈액 유래 FVIII
신선 동결 혈장
프로트롬빈 복합체
첨단 지혈
유동성 지혈제
트롬빈
피브린
합성 실란트
지혈 제품 시장 규모 : 용도별 & CAGR(2025-2032)
시장 개요
외상
수술
혈우병
심근경색
뇌졸중
혈전증
지혈 제품 시장 규모 : 최종 용도별 & CAGR(2025-2032)
시장 개요
병원
외래 수술 센터
기타
지혈 제품 시장 규모 : 지역별 & CAGR(2025-2032)
북미
미국
캐나다
유럽
독일
스페인
프랑스
영국
이탈리아
기타 유럽 지역
아시아태평양
중국
인도
일본
한국
기타 아시아태평양
라틴아메리카
브라질
기타 라틴아메리카 지역
중동 및 아프리카
GCC 국가
남아프리카공화국
기타 중동 및 아프리카
경쟁 정보
상위 5사의 비교
주요 기업의 시장 포지셔닝(2024년)
주요 시장 기업이 채택한 전략
최근 시장 동향
기업의 시장 점유율 분석(2024년)
주요 기업의 기업 개요
기업의 상세
제품 포트폴리오 분석
기업의 부문별 점유율 분석
매출의 전년대비 비교(2022-2024)
주요 기업 개요
CSL Behring(Australia)
Haemonetics Corporation(USA)
Octapharma AG(Switzerland)
Baxter International Inc.(USA)
Johnson & Johnson(USA)
Pfizer Inc.(USA)
Becton, Dickinson and Company(USA)
Medtronic plc(Ireland)
Siemens Healthineers AG(Germany)
Abbott Laboratories(USA)
Roche Holding AG(Switzerland)
Thermo Fisher Scientific Inc.(USA)
Grifols, S.A.(Spain)
Instrumentation Laboratory(Werfen)(USA)
Stago Group(France)
Sysmex Corporation(Japan)
Siemens Healthineers AG(Germany)
Danaher Corporation(USA)
LivaNova PLC(UK)
CryoLife, Inc.(USA)
결론과 제안
KSA
영문 목차
영문목차
Hemostasis Products Market size was valued at USD 1.69 billion in 2023 and is poised to grow from USD 1.78 billion in 2024 to USD 2.74 billion by 2032, growing at a CAGR of 5.5% during the forecast period (2025-2032).
The global hemostasis products market is experiencing consistent growth, fueled by heightened awareness and medical technology advancements. Essential for controlling bleeding during surgeries, trauma, and managing bleeding disorders, the demand for these products is amplified by an aging population and an increase in chronic diseases and surgical procedures. Additionally, improvements in healthcare infrastructure in developing regions are further propelling market expansion. Ongoing research and development are introducing innovative, safer, and more efficient hemostasis products. Nevertheless, regulatory hurdles and the high costs associated with these products present challenges to market growth. Despite these obstacles, the market is set for continued progress as healthcare standards and technological innovations evolve.
Top-down and bottom-up approaches were used to estimate and validate the size of the Hemostasis Products market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Hemostasis Products Market Segments Analysis
Global Hemostasis Products Market is segmented by Products, Application, End Use and region. Based on Products, the market is segmented into Topical Hemostasis, Infusible Hemostasis and Advanced Hemostasis. Based on Application, the market is segmented into Trauma, Surgery, Hemophilia, Myocardial Infarction, Stroke and Thrombosis. Based on End Use, the market is segmented into Hospitals, Ambulatory Surgical Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Hemostasis Products Market
The Hemostasis Products market is significantly driven by innovations that focus on the development of safer and more environmentally friendly hemostatic solutions, including advanced agents and devices. These advancements not only enhance the management of bleeding complications and surgical processes but also contribute to better patient outcomes. As these improved products gain traction, they are stimulating growth within the market, leading to increased demand for effective hemostatic solutions. The ongoing emphasis on safety and effectiveness in hemostasis products plays a crucial role in shaping the future of medical practices related to bleeding control and surgical interventions.
Restraints in the Hemostasis Products Market
A significant challenge in the hemostasis products market is the high cost of these items. The elevated prices can limit accessibility for healthcare facilities with constrained budgets, as well as for patients in various regions. This financial barrier may impede the widespread adoption of advanced hemostasis solutions, ultimately restricting their market penetration. As a result, the impact on patient care could be substantial, as many healthcare providers may struggle to incorporate these critical products into their treatment protocols due to budgetary constraints, leading to disparities in the quality of care available to patients.
Market Trends of the Hemostasis Products Market
The Hemostasis Products market is witnessing a notable trend toward minimally invasive techniques, driven by a collective demand from healthcare providers and patients for less invasive solutions to manage bleeding during surgical procedures. This shift is propelling the development of advanced hemostasis products that minimize tissue damage, streamline recovery times, and enhance overall patient outcomes. As these techniques gain popularity, they offer increased patient comfort and shorter hospital stays, aligning perfectly with the healthcare industry's broader focus on value-based care. Consequently, manufacturers are innovating rapidly to meet these evolving needs, making the market poised for substantial growth.
Table of Contents
Introduction
Objectives of the Study
Scope of the Report
Definitions
Research Methodology
Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations
Executive Summary
Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis
Market Dynamics & Outlook
Market Overview
Market Size
Market Dynamics
Drivers & Opportunities
Restraints & Challenges
Porters Analysis
Competitive rivalry
Threat of substitute
Bargaining power of buyers
Threat of new entrants
Bargaining power of suppliers
Key Market Insights
Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Global Hemostasis Products Market Size by Products & CAGR (2025-2032)
Market Overview
Topical Hemostasis
Collagen
Oxidized Regenerated Cellulose
Gelatin
Polysaccharide
Infusible Hemostasis
Platelet Concentrates from Donor Blood
FVIII Derived from Blood
Fresh Frozen Plasma
Prothrombin Complex
Advanced Hemostasis
Flowable
Thrombin
Fibrin
Synthetic Sealants
Global Hemostasis Products Market Size by Application & CAGR (2025-2032)
Market Overview
Trauma
Surgery
Hemophilia
Myocardial Infarction
Stroke
Thrombosis
Global Hemostasis Products Market Size by End Use & CAGR (2025-2032)
Market Overview
Hospitals
Ambulatory Surgical Centers
Others
Global Hemostasis Products Market Size & CAGR (2025-2032)
North America (Products, Application, End Use)
US
Canada
Europe (Products, Application, End Use)
Germany
Spain
France
UK
Italy
Rest of Europe
Asia Pacific (Products, Application, End Use)
China
India
Japan
South Korea
Rest of Asia-Pacific
Latin America (Products, Application, End Use)
Brazil
Rest of Latin America
Middle East & Africa (Products, Application, End Use)
